Video

Managing Novel Therapy AEs in Sickle Cell Disease

Author(s):

HCP Live

Related Videos
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Elna Saah, MD: Unraveling the Current Landscape of Sickle Cell Disease | Image Credit: Twitter
Hematopoietic Stem Cell Transplantation Improves Pediatric SCD Outcomes | Image Credit: Scott Graham/Unsplash
Dunia Hatabah, MD | Image Credit: HCPLive
Related Content
Yvonne Dei-Adomakoh, MBBS, hematologist at the University of Ghana Medical School Korle Bu Teaching Hospital in Accra, Ghana
December 8th 2024

Hydroxyurea Shows Clinical Benefit in HbSC, Misses the Mark on Safety

Victoria Johnson
The Cultural and Clinical Challenges of Sickle Cell with Ifeyinwa “Ify” Osunkwo, MD
February 10th 2022

The Cultural and Clinical Challenges of Sickle Cell with Ifeyinwa “Ify” Osunkwo, MD

Dexamethasone Raises VTE Risk in Sickle Cell Cases Admitted for COVID-19 | Image Credit: Johns Hopkins University
December 4th 2024

Dexamethasone Raises VTE Risk in COVID-19 Cases with Sickle Cell

Connor Iapoce
The Sickle Cell Disease Cycle with Ify Osunkwo, MD
February 7th 2022

The Sickle Cell Disease Cycle with Ify Osunkwo, MD

Kevin Kunzmann
Cognitive Dysfunction Common in Patients with Sickle Cell Anemia | Image Credit: Jan Krivec/Unsplash
October 14th 2024

Cognitive Dysfunction Common in Patients with Sickle Cell Anemia

Connor Iapoce
Social Determinants of Health Shape Pain Outcomes in Sickle Cell Disease| Image Credit: Towfiqu barbhuiya/Unsplash
October 8th 2024

Social Determinants of Health Shape Pain Outcomes in Sickle Cell Disease

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.